A new public health genomics model for common complex diseases, with an application to common behavioral disorders

Personalized Medicine
Bahar TaneriAngela Brand

Abstract

In the light of common forms of gene-environment interplay, particularly epigenomics and ecogenetics, the incorporation of envirome data into public health genomics models becomes necessary. Developing and restructuring public health genomics models is essential within the context of common complex diseases. We developed a novel theoretical model integrating a gene-environment interaction paradigm into public health genomics, which integrates four main sources of data: personal genome data, personal envirome data, molecular genetic/genomic evidence and environmental factors implicated in gene-environment interactions underlying common complex disease phenotypes. Collectively, this knowledge is fed into public health policy development. This model is the first public health genomics model that incorporates gene-environment interactions within the context of common complex disorders, and is applied to behavioral conditions. Our model proposes, for the first time, an understanding of behavioral disorders from the genomic perspective, combining it with known environmental factors within the framework of public health. Application of this model will enable evidence-based behavioral interventions at the public health level and facili...Continue Reading

References

Apr 24, 2001·The British Journal of Psychiatry. Supplement·J M Neiderhiser
Apr 24, 2001·The British Journal of Psychiatry. Supplement·J C Anthony
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·M P Scheid, J R Woodgett
Aug 6, 2002·Science·Avshalom CaspiRichie Poulton
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Jun 6, 2003·Current Opinion in Genetics & Development·Ken Inoue, James R Lupski
Oct 25, 2003·Science·Kathleen Ries Merikangas, Neil Risch
Feb 22, 2005·Current Molecular Medicine·Penelope K Manasco
Mar 23, 2005·Biological Psychiatry·Deepak Cyril D'SouzaJohn Harrison Krystal
Apr 21, 2005·American Journal of Epidemiology·Muin J KhouryPaula Yoon
May 3, 2006·Human Molecular Genetics·Pauline A Callinan, Andrew P Feinberg
Feb 20, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Philippa J Talmud
Mar 8, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andreas ReifWolfgang Retz
Mar 17, 2007·Nature Reviews. Genetics·Randy L Jirtle, Michael K Skinner
May 9, 2007·Journal of Neurochemistry·Andrés OzaitaRafael Maldonado
Oct 11, 2007·Nature Reviews. Neuroscience·Robin M MurrayMarta Di Forti
Oct 24, 2007·Biological Psychiatry·Marcus R MunafòAhmad R Hariri
Dec 13, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Muin J KhouryLinda Bradley
Mar 14, 2008·Current Drug Metabolism·Virendra S Gomase, Somnath Tagore
Mar 28, 2008·PLoS Biology·Timothy CaulfieldMichael Timmons
Apr 30, 2008·Human Mutation·Jan HaavikBeat Thöny
May 3, 2008·Acta Psychiatrica Scandinavica·M KoningsJ Van Os
Aug 30, 2008·Schizophrenia Bulletin·Cécile HenquetRobin M Murray
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Amy L McGuire, Wylie Burke
Mar 5, 2009·European Journal of Human Genetics : EJHG·Christine PatchMartina C Cornel
Mar 5, 2009·European Journal of Human Genetics : EJHG·David Gurwitz, Yael Bregman-Eschet
Nov 27, 2009·Genome Medicine·Pascal Borry
Jun 30, 2010·PLoS Genetics·Greg Gibson, Gregory P Copenhaver
Oct 6, 2010·Archives of General Psychiatry·UNKNOWN Genetic Risk and Outcome in Psychosis (GROUP) Investigators
Oct 30, 2010·Advances in Genetics·Yan V Sun
Nov 3, 2010·Archives of General Psychiatry·Ruud van Winkel, UNKNOWN Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Nov 12, 2010·Nature·Jim van OsBart P F Rutten
Jan 13, 2011·Psychopharmacology·Nicole R NugentLawrence H Price

❮ Previous
Next ❯

Citations

Aug 10, 2013·American Journal of Public Health·Abdulrahman M El-SayedSandro Galea

❮ Previous
Next ❯

Software Mentioned

GxE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Headache and Pain
Paolo GaragnaniPietro Cortelli
Environmental Health Perspectives
J W Albers
Genetic Testing and Molecular Biomarkers
Amanda FieldSharon F Terry
© 2022 Meta ULC. All rights reserved